Ignite Creation Date:
2024-05-06 @ 11:01 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03410693
Status:
COMPLETED
Last Update Posted:
2022-09-28
First Post:
2018-01-19
Brief Title:
Study of Rogaratinib BAY1163877 vs Chemotherapy in Patients With FGFR Fibroblast Growth Factor Receptor-Positive Locally Advanced or Metastatic Urothelial Carcinoma
Sponsor:
Bayer
Organization:
Bayer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-31
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-27
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-19
First Submit QC Date:
January 19 2018
Study First Post Date:
2018-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-12-29
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-25
Last Update Post Date:
2022-09-28
Last Update Post Date Type:
ACTUAL